These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

453 related articles for article (PubMed ID: 25441748)

  • 1. Response to intravenous iron in patients with iron deficiency anemia (IDA) and restless leg syndrome (Willis-Ekbom disease).
    Mehmood T; Auerbach M; Earley CJ; Allen RP
    Sleep Med; 2014 Dec; 15(12):1473-6. PubMed ID: 25441748
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Lower molecular weight intravenous iron dextran for restless legs syndrome.
    Cho YW; Allen RP; Earley CJ
    Sleep Med; 2013 Mar; 14(3):274-7. PubMed ID: 23333678
    [TBL] [Abstract][Full Text] [Related]  

  • 3. A double-blind, placebo-controlled trial of intravenous iron dextran therapy in patients with ESRD and restless legs syndrome.
    Sloand JA; Shelly MA; Feigin A; Bernstein P; Monk RD
    Am J Kidney Dis; 2004 Apr; 43(4):663-70. PubMed ID: 15042543
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Intravenous iron dextran for severe refractory restless legs syndrome.
    Ondo WG
    Sleep Med; 2010 May; 11(5):494-6. PubMed ID: 20371212
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Restless Leg Syndrome/Willis-Ekbom disease in women with iron deficiency anemia.
    Kolukisa M; Soysal P; Gületkin TÖ; Karatoprak C; Bilgen HR; Gürsoy AE
    Ideggyogy Sz; 2016 Sep; 69(9-10):356-360. PubMed ID: 29638100
    [TBL] [Abstract][Full Text] [Related]  

  • 6. A randomized double-blind pilot study to evaluate the efficacy, safety, and tolerability of intravenous iron versus oral iron for the treatment of restless legs syndrome in patients with iron deficiency anemia.
    Short V; Allen R; Earley CJ; Bahrain H; Rineer S; Kashi K; Gerb J; Auerbach M
    Am J Hematol; 2024 Jun; 99(6):1077-1083. PubMed ID: 38476079
    [TBL] [Abstract][Full Text] [Related]  

  • 7. The treatment of restless legs syndrome with intravenous iron dextran.
    Earley CJ; Heckler D; Allen RP
    Sleep Med; 2004 May; 5(3):231-5. PubMed ID: 15165528
    [TBL] [Abstract][Full Text] [Related]  

  • 8. The prevalence and impact of restless legs syndrome on patients with iron deficiency anemia.
    Allen RP; Auerbach S; Bahrain H; Auerbach M; Earley CJ
    Am J Hematol; 2013 Apr; 88(4):261-4. PubMed ID: 23494945
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Multiple blood donations associated with iron deficiency in patients with restless legs syndrome.
    Silber MH; Richardson JW
    Mayo Clin Proc; 2003 Jan; 78(1):52-4. PubMed ID: 12528877
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Ferric carboxymaltose effects on restless legs syndrome and on brain iron in patients with iron deficiency anemia.
    Bae H; Cho YW; Kim KT; Li X; Earley CJ
    Sleep Med; 2023 Sep; 109():128-131. PubMed ID: 37437492
    [TBL] [Abstract][Full Text] [Related]  

  • 11. [Geriatric inpatients with iron deficiency-associated Restless Legs Syndrome. A retrospective analysis].
    Lieske B; Röhrig G; Becker I; Schulz RJ; Polidori MC; Kassubek J
    MMW Fortschr Med; 2017 Mar; 159(Suppl 4):12-17. PubMed ID: 28244024
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Willis-Ekbom Disease Foundation revised consensus statement on the management of restless legs syndrome.
    Silber MH; Becker PM; Earley C; Garcia-Borreguero D; Ondo WG;
    Mayo Clin Proc; 2013 Sep; 88(9):977-86. PubMed ID: 24001490
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Randomized, placebo-controlled trial of ferric carboxymaltose in restless legs syndrome patients with iron deficiency anemia.
    Bae H; Cho YW; Kim KT; Allen RP; Earley CJ
    Sleep Med; 2021 Aug; 84():179-186. PubMed ID: 34157632
    [TBL] [Abstract][Full Text] [Related]  

  • 14. The prevalence and clinical characteristics of restless legs syndrome in patients with iron deficiency anemia in Korea.
    Bae H; Kim KT; Heo MH; Do YR; Cho YW
    J Clin Sleep Med; 2021 Jul; 17(7):1447-1452. PubMed ID: 33704047
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Which Factors in Spinocerebellar Ataxia Type 3 Patients Are Associated with Restless Legs Syndrome/Willis-Ekbom Disease?
    Gitaí LLG; Éckeli AL; Sobreira-Neto MA; Diniz PRB; Santos AC; Júnior WM; Fernandes RMF
    Cerebellum; 2021 Feb; 20(1):21-30. PubMed ID: 32946033
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Intravenous low molecular weight iron dextran in children with iron deficiency anemia unresponsive to oral iron.
    Plummer ES; Crary SE; McCavit TL; Buchanan GR
    Pediatr Blood Cancer; 2013 Nov; 60(11):1747-52. PubMed ID: 23832487
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Natural course of restless legs syndrome/Willis-Ekbom disease: long-term observation of a large clinical cohort.
    Mitterling T; Heidbreder A; Stefani A; Fritz J; Ulmer H; Poewe W; Högl B
    Sleep Med; 2015 Oct; 16(10):1252-8. PubMed ID: 26429754
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Altered brain iron homeostasis and dopaminergic function in Restless Legs Syndrome (Willis-Ekbom Disease).
    Earley CJ; Connor J; Garcia-Borreguero D; Jenner P; Winkelman J; Zee PC; Allen R
    Sleep Med; 2014 Nov; 15(11):1288-301. PubMed ID: 25201131
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Willis-Ekbom Disease or Restless Legs Syndrome?
    Carlos K; Prado LB; Carvalho LB; Prado GF
    Sleep Med; 2015 Sep; 16(9):1156-9. PubMed ID: 26298794
    [TBL] [Abstract][Full Text] [Related]  

  • 20. [Treatment of secondary restless legs syndrome].
    Gross N; Winkelmann J
    MMW Fortschr Med; 2011 May; 153(21):45-8; quiz 49. PubMed ID: 21736066
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 23.